Diameter Capital Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-815,207
Closed -$54.6M 133
2021
Q2
$54.6M Buy
815,207
+315,207
+63% +$19.5M 3.71% 6
2021
Q1
$26M Buy
+500,000
New +$25.3M 2.73% 10
2020
Q1
Sell
-358,069
Closed -$13.6M 23
2019
Q4
$13.6M Sell
358,069
-6,931
-2% -$208K 1.32% 14
2019
Q3
$8.07K Sell
365,000
-103,954
-22% -$2.21M 2.85% 8
2019
Q2
$9.69K Buy
468,954
+128,954
+38% +$2.97M 1.97% 13
2019
Q1
$9.81M Buy
340,000
+140,000
+70% +$3.46M 3.43% 12
2018
Q4
$3.43M Buy
+200,000
New +$4.84M 1.56% 15
2018
Q2
Sell
-335,000
Closed -$10.4M 26
2018
Q1
$8.12M Buy
335,000
+60,000
+22% +$1.19M 1.75% 11
2017
Q4
$4.17M Buy
+275,000
New +$3.87M 1.87% 11

Other funds holding THC

Diameter Capital Partners's THC Position: Q3 2021 in Review

Diameter Capital Partners sold out of Tenet Healthcare (THC) in Q3 2021, closing a stake of 815,207 shares — an estimated $54.6M sold.

Diameter Capital Partners first reported a position in THC in Q4 2017 and held it in 9 quarters. The position peaked at $54.6M in Q2 2021. 336 funds tracked by Wall St. Rank hold THC as of Q3 2021.

  • Diameter Capital Partners reported no remaining Tenet Healthcare position as of Q3 2021 after selling out during the quarter.
  • Diameter Capital Partners sold 815,207 Tenet Healthcare shares in Q3 2021, an estimated $54.6M.
  • Diameter Capital Partners first reported a position in Tenet Healthcare in Q4 2017 and held it in 9 quarters.
  • Diameter Capital Partners's Tenet Healthcare position peaked at $54.6M in Q2 2021.
  • 336 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2021.

Based on Diameter Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.